OliX PharmaceuticalsI Return On Equity vs. Cash Flow From Operations

226950 Stock   21,000  100.00  0.48%   
Considering the key profitability indicators obtained from OliX PharmaceuticalsI's historical financial statements, OliX PharmaceuticalsInc may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess OliX PharmaceuticalsI's ability to earn profits and add value for shareholders.
For OliX PharmaceuticalsI profitability analysis, we use financial ratios and fundamental drivers that measure the ability of OliX PharmaceuticalsI to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well OliX PharmaceuticalsInc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between OliX PharmaceuticalsI's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of OliX PharmaceuticalsInc over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between OliX PharmaceuticalsI's value and its price as these two are different measures arrived at by different means. Investors typically determine if OliX PharmaceuticalsI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, OliX PharmaceuticalsI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

OliX PharmaceuticalsInc Cash Flow From Operations vs. Return On Equity Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining OliX PharmaceuticalsI's current stock value. Our valuation model uses many indicators to compare OliX PharmaceuticalsI value to that of its competitors to determine the firm's financial worth.
OliX PharmaceuticalsInc is rated fourth in return on equity category among its peers. It is rated second in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value OliX PharmaceuticalsI by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for OliX PharmaceuticalsI's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

OliX Cash Flow From Operations vs. Return On Equity

Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.

OliX PharmaceuticalsI

Return On Equity

 = 

Net Income

Total Equity

 = 
-76.63
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

OliX PharmaceuticalsI

Operating Cash Flow

 = 

EBITDA

-

Taxes

 = 
(19.05 B)
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.

OliX Cash Flow From Operations Comparison

OliX PharmaceuticalsI is currently under evaluation in cash flow from operations category among its peers.

OliX Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on OliX PharmaceuticalsI. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of OliX PharmaceuticalsI position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the OliX PharmaceuticalsI's important profitability drivers and their relationship over time.

Use OliX PharmaceuticalsI in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OliX PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OliX PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.

OliX PharmaceuticalsI Pair Trading

OliX PharmaceuticalsInc Pair Trading Analysis

The ability to find closely correlated positions to OliX PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OliX PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OliX PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OliX PharmaceuticalsInc to buy it.
The correlation of OliX PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OliX PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OliX PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OliX PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your OliX PharmaceuticalsI position

In addition to having OliX PharmaceuticalsI in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gambling Thematic Idea Now

Gambling
Gambling Theme
Companies that are related to providing gambling services across multiple geographical areas by investing, exploring, or producing software, hardware, and related infrastructure for running gambling operations or trading speculative assets. The Gambling theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gambling Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in OliX Stock

To fully project OliX PharmaceuticalsI's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of OliX PharmaceuticalsInc at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include OliX PharmaceuticalsI's income statement, its balance sheet, and the statement of cash flows.
Potential OliX PharmaceuticalsI investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although OliX PharmaceuticalsI investors may work on each financial statement separately, they are all related. The changes in OliX PharmaceuticalsI's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on OliX PharmaceuticalsI's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.